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PU.1 expression is modulated
by the balance of functional sense
and antisense RNAs regulated
by a shared cis-regulatory element
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The transcription factor PU.1 is an important regulator of hematopoiesis; precise expression levels are critical
for normal hematopoietic development and suppression of leukemia. We show here that noncoding antisense
RNAs are important modulators of proper dosages of PU.1. Antisense and sense RNAs are regulated by shared
evolutionarily conserved cis-regulatory elements, and we can show that antisense RNAs inhibit PU.1
expression by modulating mRNA translation. We propose that such antisense RNAs will likely be important
in the regulation of many genes and may be the reason for the large number of overlapping complementary
transcripts with so far unknown function.
[Keywords: Noncoding antisense RNA; upstream and intronic regulatory elements; coordinated expression of
the target and regulator; translation stalling]
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Recent genomic studies are uncovering an abundance of
bidirectional transcription of eukaryotic genes across
metazoan genomes (Werner and Berdal 2005) and have
revealed a large number of overlapping transcripts in
∼50% of all investigated cases (Cheng et al. 2005). These
and other recent reports are changing the notion of natu-
ral antisense transcripts as transcriptional noise and
rather suggest an important role as regulatory tools in
the fine regulation of genes (Lee and Lu 1999; Sleutels et
al. 2002; Katayama et al. 2005). However, very little is
known about the precise function of natural antisense
transcripts as well as the molecular mechanisms of their
biogenesis.
The transcription factor PU.1 is a hematopoietic lin-
eage-specific ETS family member (Moreau-Gachelin et
al. 1988) that is absolutely required for normal hemato-
poiesis (Tenen 2003). The level of PU.1 expression is
critical for specifying cell fate, and, if perturbed, even
modest decreases in PU.1 can lead to leukemias and lym-
phomas (Moreau-Gachelin et al. 1988; DeKoter and
Singh 2000; Anderson et al. 2002; Rothenberg and Ander-
son 2002; Dahl et al. 2003; Cook et al. 2004; Rosenbauer
et al. 2004, 2006; Huang et al. 2008). Previous reports
demonstrated regulation of the PU.1 gene through the
proximal promoter (Chen et al. 1995) and an upstream
regulatory element (URE) located −14 kb and −17 kb up-
stream of the transcription start sites (TSS) in mice and
humans, respectively (Li et al. 2001; Rosenbauer et al.
2004; Okuno et al. 2005). Removal of the URE by ho-
mologous recombination resulted in 80% reduction of
PU.1 expression in bone marrow compared with wild-
type mice and development of leukemias and lympho-
mas (Rosenbauer et al. 2004, 2006).
In this study, we demonstrate that the PU.1 locus
gives rise to both mRNA and natural noncoding anti-
sense transcripts that are originating from an intronic
promoter. We show that these antisense transcripts have
a regulatory function and control PU.1 gene expression
via the regulation of translation. We demonstrate that
the URE is required to drive both sense and antisense
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transcription, and that the URE physically interacts with
both sense and antisense promoters. Our results demon-
strate a novel mechanism of control of gene regulation
through coordinated expression of the target gene and its
regulatory natural antisense transcripts.
Results
Identification of naturally occurring antisense
transcripts overlapping the PU.1 coding region
We discovered the presence of antisense transcripts in
the intronic regions (introns 1, 2, and 3) and in the region
upstream of the PU.1 mRNA TSS (Fig. 1A). These tran-
scripts were found in a variety of PU.1 expressing and
nonexpressing human and murine tissue culture and pri-
mary hematopoietic cells (Supplemental Fig. S1). 5-
RACE experiments revealed the antisense TSS (ATSS) in
intron 3 (Supplemental Fig. S2). Interestingly, the ATSS
was located within an evolutionarily conserved cis-ele-
ment within intron 3 (H3) (Fig. 1A; Supplemental Fig.
S3). Like the URE and the proximal promoter, H3 coin-
cided with a previously reported DNase I-hypersensitive
site (Li et al. 2001), which indicates regions bound by
active transcription factor complexes. We could not de-
Figure 1. Both strands of the PU.1 gene are transcribed, and homology region H3 confers promoter activity in the antisense orien-
tation. (A, top panel) Linear diagram showing the positions of the PU.1 gene locus homology regions URE (H1 + H2), proximal
promoter (PrPr), and H3, as well as exons 1–5 (E1–E5). (Bottom panel) Diagram showing the position of the sense- and antisense-specific
primers in exon 3 (block arrows), and the ATSS (star), corresponding to antisense RNA (AS; long black arrow). The long white arrow
indicates the orientation of the sense RNA (S; PU.1 mRNA). Two short black arrows indicate orientation of the homology region H3
fragment–luciferase constructs (H3-S and H3-AS, sense and antisense, respectively). (B) Quantification of the PU.1 gene antisense
transcripts by real-time strand-specific RT–PCR in HL-60 and RAW 264.7 cells. Strand-specific RT was performed for sense RNA (PU.1
mRNA) and for antisense RNA (AS) using sense- and antisense-specific primers (as shown in A), followed by PCR with the respective
primer pair (see the Supplemental Material for oligonucleotide sequences and the Materials and Methods and legend to Supplemental
Fig. S1 for a detailed protocol for strand-specific RT–PCR). Expression values are shown as the percent of sense transcript expression
(100%). Mean values and standard deviation (error bars) based on three real-time PCR runs are displayed. (C) Antisense RNAs (AS) are
more stable than sense RNAs (S). Shown is a time course of sense and antisense RNA levels isolated from bone marrow mononuclear
cells derived from wild-type mice. Cells were treated with Actinomycin D (Alexis Biochemicals) at 10 µg/mL. An equal amount of
viable cells (0.5 million), counted after Ficoll gradient purification, were collected at 0, 1, 6.5, and 8 h of treatment. Total RNA was
isolated as described in the Materials and Methods and subjected to sense- and antisense-specific quantitative RT–PCR. The primers
used for quantitative RT–PCR are described in the Supplemental Material, “Primers Used for Real-Time RT–PCR,” and shown in
Supplemental Figure S1A. Correlation coefficients (R2) and equations of the exponential regression curves are indicated. (D) Homology
region H3 confers promoter activity in the antisense orientation. The 215-bp fragment of homology region H3 was inserted into the
pXP2 luciferase reporter vector in both sense (H3-S) and antisense (H3-AS) orientation. The PU.1 proximal promoter (PrPr) construct
was described previously (Li et al. 2001). The pXP2 luciferase vector alone, as well as vectors including the PU.1 proximal promoter
or H3 constructs were transiently transfected into HL-60 (left panel) and Jurkat (right panel) cells. Shown is the fold change in
luciferase activity compared with pXP2 alone. Data are presented as the mean ± standard deviation based on three to six data points
for each construct.
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tect antisense 3 ends by 3-RACE, probably due to the
fact that these transcripts are heterogeneous in length
and are very large in size, >9 kb. Northern blotting analy-
sis revealed an almost equal amount of the antisense
transcripts within the nuclear and cytoplasmic compart-
ments and partial polyadenylation of the antisense
RNAs; the majority of the detected antisense transcripts
were not polyadenylated (data not shown). We quantified
relative levels of the antisense RNAs by real-time PCR
(Fig. 1B). The levels of antisense RNAs were ∼12%–15%
of PU.1 mRNA level (sense transcript) in high-PU.1-ex-
pressing human and murine cells (HL-60 and RAW
264.7). Finally, we assessed the stability of sense and
antisense transcripts. Noteworthy, the antisense RNA
turned out to be stable, and its half-life was markedly
higher than that of PU.1 mRNA (Fig. 1C).
Expression of both sense and antisense PU.1 gene
RNAs is dependent on the URE
Little is known about the molecular details of what regu-
lates the biosynthesis of natural antisense RNA tran-
scripts. To test for a possible cis-regulatory function of
the PU.1 intron 3 fragment, we analyzed luciferase con-
structs fused to the entire conserved H3 region (Fig. 1A).
The results demonstrate that H3 has promoter activity
and can activate the luciferase gene in both high-PU.1-
expressing (HL-60) and in nonexpressing (Jurkat) cells.
Importantly, elevated activity was observed only when
H3 was oriented in the antisense direction (Fig. 1D).
To test whether the distant PU.1 gene regulatory ele-
ment URE was also involved in regulation of PU.1 anti-
sense RNAs, we measured antisense transcript levels in
cells derived from the URE/ mouse model, in which
the URE had been genetically deleted in vivo (Fig. 2A;
Rosenbauer et al. 2004), and compared these levels with
that in wild-type animals. We found an almost identical
reduction of PU.1 sense and antisense transcripts in mu-
tant animals (∼85% and ∼81%, respectively, [Fig. 2B–D]
and ∼78% and ∼74%, respectively [Supplemental Fig.
S4]), demonstrating that the URE is involved in regula-
tion of both RNAs. The reduction in antisense RNA was
not due to destabilization, because the pattern of poly-
adenylated antisense transcripts in the URE/ mouse
model (Rosenbauer et al. 2004) was largely identical to
that observed in wild-type animals (Supplemental Fig.
S5B,C). Furthermore, the direct assessment of stability of
total antisense RNAs in wild type and URE/ again re-
vealed no significant difference (Supplemental Fig. S5D).
In summary, our data demonstrate that the biogenesis of
PU.1 gene mRNA as well as antisense RNAs rely on the
URE.
The URE interacts with both the sense
and the antisense promoters
We tested whether the URE exerts its functional role
through a direct interaction with H3 by using chromo-
some conformation capture (3C), which is based on
cross-linking between distant chromosomal elements
(Dekker et al. 2002; Tolhuis et al. 2002; Spilianakis et al.
2005). We applied a modified quantitative 3C protocol to
Figure 2. The URE is instrumental in PU.1 anti-
sense RNA synthesis. (A) The linear diagram
shows the position of the PU.1 gene locus homol-
ogy regions: the URE (H1 + H2), removed by ho-
mologous recombination (Rosenbauer et al. 2004),
proximal promoter (PrPr), and H3; initiation sites
and orientation of the sense (long white arrow) and
antisense (long black arrow) transcripts; and the
position of the antisense-specific probe (pentagon).
(B) Northern blot analysis illustrates down-regula-
tion of the antisense RNAs in the URE/ mouse
model (Rosenbauer et al. 2004). RNAs were iso-
lated from bone marrow of wild-type (+/+) and hy-
pomorphic (/) animals. Two micrograms of
polyA(+) were run side by side and hybridized with
the probe specific to antisense RNAs (pentagon,
A). The top panel demonstrates down-regulation
of antisense RNAs. The middle panel demon-
strates down-regulation of the PU.1 sense mRNA
in the URE/ mouse model, using a double-
stranded murine PU.1 cDNA probe. The bottom
panel depicts GAPDH mRNA levels as loading
controls (see the Supplemental Material for the
probe information). (C,D) The URE regu-
lates expression of both sense and antisense RNAs. Relative sense and antisense RNA levels in bone marrow of wild type and animals
with an URE deletion were quantitated by Northern blot phosphorescence imaging (normalized to GAPDH mRNA) (C) and, as
corroboration, by strand-specific RT–PCR (graph values calculated as mean ± standard deviation of three real-time RT–PCR runs,
normalized to GAPDH mRNA, measured by TaqMan real-time analysis) (D). See the Supplemental Material for the TaqMan probes
and primers used for strand-specific RT–PCR.
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the murine macrophage RAW 264.7 cell line. In these
experiments, we quantified the cross-linking efficiencies
between the distant regulatory element URE and several
regions in the PU.1 locus extending from 5 kb upstream
of to 20 kb downstream from the TSS (Fig. 3A). To avoid
problems with the nonlinearity of PCR, we developed a
simple and accurate approach exploiting Southern blot
hybridization combined with further phosphorescence
imaging (described in detail in the Supplemental Mate-
rial). 3C experiments were also performed with primary
human granulocytes and HL-60 promyelocytic cells
(Supplemental Fig. S6; data not shown) with similar re-
sults. The different experiments demonstrated that spe-
cific signals were only observed with primers located at
the URE, the proximal promoter, and the conserved H3
intronic element, but not at intervening genomic se-
quences (Fig. 3C).
As depicted in Figure 3D, the results of the 3C experi-
ments demonstrate that the URE controls the levels of
sense and antisense transcription by physically interact-
ing with the proximal promoter and the intronic con-
served element, H3.
PU.1-encoded antisense transcripts negatively regulate
PU.1 expression
To test for a potential regulatory role of the antisense
RNAs in PU.1 expression, we performed RNAi ex-
periments with siRNAs targeting human PU.1 anti-
sense RNAs using chemically modified strand-specific
dsRNAs, thus avoiding recognition by complexes initi-
ating cellular stress responses (Stealth RNAi; Invitro-
gen). Two target regions were chosen (Fig. 4, indicated as
rhomboids). The first region was located 5 upstream of
the sense TSS, within the proximal promoter, and the
second within homology region H3. Strikingly, the
proximal promoter-specific and H3-specific siRNAs in-
duced increases in PU.1 protein levels of ∼105% and
∼210%, respectively (Fig. 4B,C) and increases in PU.1
mRNA levels of 125 ± 11% (P < 0.001) and ∼145 ± 12%
(P < 0.001), respectively (Fig. 4D,E). Similar results were
obtained with siRNAs specifically targeting PU.1 anti-
sense RNAs in U937, RAJI (human) and RAW 264.7,
416B (murine) cell lines (Supplemental Fig. S7). These
results demonstrate that the PU.1 antisense transcripts
act as negative regulators of PU.1 protein and PU.1 gene
mRNA levels in both species. This observation raises the
possibility that targeting these antisense transcripts
could be used as a novel method to increase PU.1 levels
and might provide a novel therapeutic tool to reverse the
reduction in PU.1 expression levels that were reported in
leukemias and lymphomas (Moreau-Gachelin et al.
1988; DeKoter and Singh 2000; Dahl et al. 2003; Cook et
al. 2004; Rosenbauer et al. 2004, 2006; Mueller et al.
2006; Steidl et al. 2006, 2007).
Mechanism of action of PU.1 gene antisense RNAs
There are several pathways through which PU.1 gene
antisense RNAs might regulate PU.1 gene expression in
Figure 3. Quantitative 3C assays demon-
strate the close physical proximity of the URE
to the proximal promoter and H3 antisense
promoter. (A) Diagram showing the genomic
position of the homology regions (H1–H3 and
proximal promoter [PrPr]), position and orien-
tation of the primers used in the final 3C
PCRs (common primer from the URE region:
XB1; variable downstream primers: short
horizontal arrows marked as 1–8), and loca-
tions of XbaI restriction enzyme sites (vertical
arrows); block arrows marked as 1–8 represent
calculated interaction frequencies. (B,C)
Southern blot analysis of the linear amplifica-
tion of the control and test libraries. Interac-
tion frequencies were calculated by dividing
the test 3C library (in the murine macrophage
RAW 264.7 line) signals by control library
(BAC) signals. The graphs represent results of
two independent PCR/Southern blot experi-
ments. (D) Schematic model of spatial organi-
zation of the regulatory elements of the PU.1
gene. The model depicts (1) the close physical
proximity of the PU.1 gene locus homology
regions (the URE [H1 and H2], proximal pro-
moter [PrPr], and H3) and (2) the initiation
and orientation of sense and antisense tran-
scripts (long arrows). Short block arrows indi-
cate genomic orientation of the PU.1 gene lo-
cus.
Ebralidze et al.
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hematopoietic cells. One potential pathway is RNAi
(Matzke and Birchler 2005), in which RNA silencing can
be achieved by induction of DNA methylation (RNA-
directed DNA methylation) (Morris et al. 2004) brought
about by siRNAs. We and others have observed an in-
verse correlation between levels of PU.1 promoter meth-
ylation and PU.1 mRNA expression in both human and
murine cells (Amaravadi and Klemsz 1999; A.K.
Figure 4. RNAi targeting antisense tran-
scripts leads to an increase in PU.1 protein
and PU.1 mRNA levels associated with de-
creased levels of polysomal antisense tran-
scripts. (A) Diagrams showing position of
sites in the proximal promoter and homol-
ogy region H3 used to design complemen-
tary siRNA (black and white rhomboids,
respectively). Long arrows indicate orienta-
tion of the sense (PU.1 mRNA) and
antisense (AS) transcripts. (B,C) Knock-
down of antisense transcripts using
siRNAs complementary to RNAs covering
the proximal promoter and homology re-
gion H3 in HL-60 cells leads to ∼105% and
∼210% increases in PU.1 protein, respec-
tively. Cytoplasmic and nuclear extracts
(marked C and N, respectively) (15 µg each)
isolated from cells transfected with anti-
sense-specific and unrelated siRNAs were
used for Western blot analysis. (B, top
panel) Result of probing the membrane
with PU.1 antibody. (Bottom panels) Con-
trols used were -tubulin and -actin. (C)
Relative PU.1 protein levels in nuclear
fractions of cells transfected with anti-
sense-specific siRNAs and unrelated
siRNAs. The vertical bars indicate the rela-
tive amount of PU.1 protein in nuclear
fractions normalized to -actin and shown
as the percent of PU.1 protein levels in
cells transfected with unrelated siRNAs
(100%) (NIH ImageJ version 1.37k). (D,E)
Knockdown of antisense transcripts using
siRNAs complementary to the proximal promoter or homology region H3 in HL-60 cells leads to 125% ± 11% (P < 0.001) and
145% ± 12% (P < 0.001) increase in PU.1 mRNA, respectively. (D) Northern blot analysis of the PU.1 mRNA levels in total RNA
samples using a double-stranded human PU.1 cDNA probe. GAPDH mRNA levels and ethidium bromide staining were used as
loading controls (see the Supplemental Material for probe information). (E) Histograms showing relative PU.1 gene mRNA levels in
cells either untreated or transfected with antisense-specific siRNAs or unrelated siRNAs (Invitrogen, Cat. No. 12935-400) as a control,
normalized to 18S. Expression values are shown as the percent of PU.1 mRNA levels in untreated cells (100%). Mean values and
standard deviations (error bars) based on three real-time PCR runs are displayed. (F) Knockdown of antisense transcripts using siRNAs
complementary to the proximal promoter (PrPr) and homology region H3 in HL-60 cells leads to ∼30% and ∼55% decreases in PU.1
antisense RNAs, respectively (left panel) in the cytoplasmic subfractions, and to ∼175% and ∼160% increases in PU.1 sense mRNA,
respectively (right panel). Expression values of PU.1 mRNA and antisense RNAs in the soluble cytoplasmic subfractions isolated from
the cells transfected with antisense-specific siRNAs are shown as the percent of those transfected with unrelated siRNAs (100%).
Mean values and standard deviation (error bars) based on four experiments are displayed. (G) Knockdown of antisense transcripts using
siRNAs complementary to the proximal promoter and homology region H3 in HL-60 cells leads to ∼58% and ∼78% decreases in PU.1
antisense RNAs, respectively (left panel), and to no changes in PU.1 gene mRNA levels (right panel) in the polysomal fractions.
Expression values of PU.1 mRNA and antisense RNAs in the polysomal fractions isolated from the cells transfected with antisense-
specific siRNAs are shown as the percent of those transfected with unrelated siRNAs (100%). Mean values and standard deviations
(error bars) based on four experiments are displayed. (H) Immunoprecipitation of sense/antisense PU.1 RNAs-translation factor
complexes from total polysomal fraction RNA–translation factor complexes (pRIP) using antibodies against eIF4A (translation initia-
tion factor), eEF1A (translation elongation factor), and 4E-BP1 (inhibitor of translation initiation). HL-60 cells were HCHO-cross-
linked, and total polysomal fraction was isolated as shown in Supplemental Figure 9A. pRIP was performed as described in the
Supplemental Material. Histograms show relative PU.1 gene mRNA and antisense RNA levels in the immunoprecipitates, normalized
to GAPDH (left and right panels, respectively). Mean values and standard deviations (error bars) based on three real-time PCR runs are
displayed. (I) Antisense PU.1 gene RNAs function by stalling the translation between the initiation and elongation steps. HL-60 cells
were treated with antisense-specific and unrelated siRNAs, cross-linked (1% HCHO, 10 min), and the polysomal fractions was
analyzed by pRIP with antibodies against eIF4A and eEF1A followed by real-time RT–PCR.
PU.1 expression is modulated
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Ebralidze and D.G. Tenen, unpubl.). However, we did
not detect naturally occurring siRNAs homologous to
the exonic and intronic segments of the PU.1 gene by
high-resolution Northern blot analyses (Supplemental
Fig. S8).
We therefore examined whether antisense RNAs were
regulating PU.1 translation. To directly test this hypoth-
esis, we determined changes in PU.1 mRNA and anti-
sense RNAs in different cellular compartments before
and after treatment with siRNAs against antisense
RNAs (Supplemental Fig. S9A). The purity of the frac-
tions was confirmed by TaqMan and Northern blot
analyses of U1 and U2 small nuclear RNAs (snRNAs)
(Supplemental Fig. S9B,C). We again found increases in
PU.1 protein and PU.1 mRNA levels upon siRNA treat-
ment in total cellular extracts (Supplemental Fig. S10A,B
and C, left bar graph). No down-regulation of the anti-
sense RNAs in the nuclear fractions of the samples
treated with the proximal promoter-specific and H3-spe-
cific siRNAs (Supplemental Fig. S10D, right bar graph)
was observed, suggesting that the antisense RNAi-medi-
ated effect occurred mainly in the nonnuclear compart-
ment, which is in agreement with a previous report
(Zeng and Cullen 2002). However, our results show a
clear down-regulation of antisense RNAs in the soluble
cytoplasmic subfractions (∼30% and ∼55% in samples
treated with proximal promoter- and H3-specific
siRNAs, respectively) (Fig. 4F, left bar graph), and, most
importantly, in the polysome-enriched fractions (∼69%
and ∼77% in samples treated with proximal promoter-
and H3-specific siRNAs, respectively) (Fig. 4G, left bar
graph). This indicates that this fraction contains both
sense as well as antisense RNA. Most importantly, un-
like in total, nuclear, and soluble cytoplasmic fractions
(Supplemental Fig. S10C,D, left bar graphs; Fig. 4F, right
bar graph, respectively), we did not observe increases in
PU.1 sense transcripts in fractions enriched in poly-
some-bound mRNAs (Fig. 4G, right bar graph), strongly
suggesting that the increased levels of PU.1 protein in
the siRNA-treated cells are due to an increased ratio of
sense versus antisense transcripts in the polysomes and
not a down-regulation of mRNA levels, leading to a net
increase in translation of PU.1 mRNA. Our results
therefore support a model in which the antisense tran-
script negatively regulates the PU.1 gene in myeloid
cells through translational interference. To elucidate the
mechanism of translational interference exerted by an-
tisense transcripts, we performed RNA immunoprecipi-
tation on the purified cross-linked polysomal fraction
(pRIP) with antibodies against three translation factors:
eIF4A (regulates translation initiation), eEF1A (impor-
tant for translation elongation), and 4E-BP1 (inhibitor of
translation initiation) as described (Gilbert et al. 2004;
Shamovsky et al. 2006). We detected in vivo complex
formation between PU.1 mRNA and all three factors
(Fig. 4H, left panel). In contrast, antisense RNAs formed
complexes only with the translation initiation factor
eIF4A (Fig. 4H, right panel). To test whether antisense
RNA interferes with the formation of elongating eEF1A–
mRNA complexes, we combined RNAi experiments
with pRIP (Fig. 4I). This experiment showed that this
was indeed true, since knockdown of the antisense tran-
scripts led to an ∼89%–97% increase in PU.1 mRNA
association with the elongation factor eEF1A in vivo.
These experiments suggest that antisense RNAs exert
their regulatory function through stalling translation be-
tween the initiation and elongation steps. Further mo-
lecular studies will be required to unveil the precise
mechanism of how the binding of eEF1A is inhibited.
Discussion
Functional role of PU.1 noncoding antisense RNAs
In this study, we present evidence that RNA-mediated
translational interference is not restricted to microRNAs,
but can also be mediated by long, noncoding natural an-
tisense RNAs. We hypothesize that such antisense tran-
scripts serve to keep the levels of PU.1 from being too
high in expressing cells. Antisense transcripts were also
found in cells not expressing PU.1 mRNA, similar to
what has been observed with the c-fms locus (Tagoh et
al. 2004). This may serve as an additional mechanism to
keep PU.1 completely shut off in inappropriate cells
such as T cells in which any expression would lead to
adverse affects (Anderson et al. 2002). Given the number
of sense–antisense transcription units recently discov-
ered (Cheng et al. 2005), it is likely that such a mecha-
nism will be exploited for the regulation of other genes.
Materials and methods
Detailed descriptions of methods are in the Supplemental Ma-
terial.
Primary cells, cell lines, and transient transfection
Primary human granulocytes were isolated by dextran sedimen-
tation followed by double immunomagnetic selection with
CD15. PU.1-expressing human bipotential myeloid lines HL-60
and U937 and murine macrophage RAW 264.7, and PU.1 non-
expressing human Jurkat T-cell and murine T lymphocytic
BW5147 and murine macrophage RAW 264.7 cell lines were
obtained from American Type Culture Collection. The PU.1-
expressing murine myeloid progenitor line 416B was described
previously (Dexter et al. 1979; Li et al. 2001). Transfections of
HL-60 and Jurkat cells were performed by electroporation. Pri-
mary bone marrow cells were isolated from mice harboring de-
letions of the URE (Rosenbauer et al. 2004).
RNAi knockdown of antisense transcripts
siRNA sequences, synthesis, and conditions for transfection are
described in detail in the Supplemental Material.
Preparation of nuclear, cytoplasmic, and polysomal RNAs
Biochemical fractionation of nuclei was performed by hypo-
tonic lysis with detergent followed by Dounce homogenization
followed by sucrose sedimentation. Polysomes were isolated
from cytoplasmic extracts by sucrose sedimentation. We used
methods derived from the protocols developed for nuclei isola-
tion by Blobel and Potter (1966), for cytoplasmic RNA prepara-
Ebralidze et al.
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tion by del Prete et al. (2007), and for polysome isolation by
Fennoy et al. (1997) with minor modifications.
3C
Conventional 3C protocol. We used the 3C procedure developed
by Dekker and coworkers for detection of genomic loci interac-
tions (Dekker et al. 2002).
Modified quantitative 3C protocol. We developed a modified
3C protocol using Southern blotting of PCR products and spe-
cific probes that can only hybridize with the specifically ampli-
fied ligation products. Quantitation of hybridization signals was
performed using a Storm PhosphorImager (GE Healthcare). The
method is described in detail in the Supplemental Material.
The sequences of the oligonucleotides and DNA probes used
in Northern blotting, 5- and 3−RACE, real-time and strand-
specific PCR, and 3C (including quantitation of restriction en-
zyme efficiency) are found in the Supplemental Material.
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